EAPH Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume177.00
Average Volume (3M)N/A
Market Cap
$1.34K
Enterprise Value-$23.19B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.84M
Price to Earnings (P/E)―
Beta22.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,344,933,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)0.12
Price to Sales (P/S)0.00
P/FCF Ratio-3.89
Enterprise Value/Market Cap-17.24M
Enterprise Value/Revenue66.06K
Enterprise Value/Gross Profit29.50K
Enterprise Value/Ebitda-11.56K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EAPH FAQ
What was Easton Pharmaceuticals Inc’s price range in the past 12 months?
Currently, no data Available
What is Easton Pharmaceuticals Inc’s market cap?
Easton Pharmaceuticals Inc’s market cap is $1.34K.
When is Easton Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Easton Pharmaceuticals Inc’s earnings last quarter?
Easton Pharmaceuticals Inc released its earnings results on Jun 13, 2019. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Easton Pharmaceuticals Inc overvalued?
According to Wall Street analysts Easton Pharmaceuticals Inc’s price is currently Overvalued.
Does Easton Pharmaceuticals Inc pay dividends?
Easton Pharmaceuticals Inc does not currently pay dividends.
What is Easton Pharmaceuticals Inc’s EPS estimate?
Easton Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Easton Pharmaceuticals Inc have?
Easton Pharmaceuticals Inc has 1,344,933,000 shares outstanding.
What happened to Easton Pharmaceuticals Inc’s price movement after its last earnings report?
Easton Pharmaceuticals Inc reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Easton Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in EAPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Easton Pharmaceuticals Inc
Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.